MD, MRCP (Neurology), FEBN
Brain Clinical Post Doctorial Fellow
- Fully trained Neurologist
- DPhil student in Clinical Neurosciences
- Fellow of the European Board of Neurology
- EAN Dementia and Cognitive Disorders Panel member
Digital Precision Metrics and Plasma biomarkers in Alzheimer's Disease
My research aim is to test whether by combining plasma biomarkers with digital precision cognitive metrics it is possible to develop more sensitive measures to detect Alzheimer's Disease (AD) early and track disease progression over time. I am also interested in using these tools to achieve more precise clinical stratification of subjects at risk of developing AD, such as patients with Subjective Cognitive Impairment (SCI) and Mild Cognitive Impairment (MCI). My work combines individual digital behavioural fingerprints, obtained though tablet or computer based assessments, and biological blood-derived markers of AD pathology. I also use neuroimaging to investigate the structural and functional correlates of these digital behavioural metrics in SCI, MCI and AD patients.
Vividness of visual imagery questionnaire scores and their relationship to visual short-term memory performance.
Tabi YA. et al, (2021), Cortex, 146, 186 - 199
Assessment of apathy in neurological patients using the Apathy Motivation Index caregiver version.
Klar VS. et al, (2021), J Neuropsychol
Dementia and COVID-19, a Bidirectional Liaison: Risk Factors, Biomarkers, and Optimal Health Care.
Toniolo S. et al, (2021), J Alzheimers Dis, 82, 883 - 898
Is the Frontal Lobe the Primary Target of SARS-CoV-2?
Toniolo S. et al, (2021), J Alzheimers Dis, 81, 75 - 81
Modulation of Brain Hyperexcitability: Potential New Therapeutic Approaches in Alzheimer's Disease.
Toniolo S. et al, (2020), Int J Mol Sci, 21